Basel Medical Group (BMGL) said Monday it closed an initial public offering of 2.2 million shares at $4 each to raise $8.8 million in gross proceeds.
The Singapore-based medical services provider has granted the underwriters a 45-day option to purchase up to 330,750 additional shares.
Basel Medical plans to use the net proceeds for potential mergers and acquisitions, and business expansion, among other things.
The shares began trading Feb. 25 on Nasdaq under the ticker symbol "BMGL."
The company said it has registered for the resale of up to 2 million shares by certain shareholders.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.